Biggest News Aggregation in the World

David Kuter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Kuter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Kuter Today - Breaking & Trending Today

Rigel Announces Top-line Results from FORWARD Phase 3 Clinical Trial of Fostamatinib in Patients with Warm Autoimmune Hemolytic Anemia

Published: June 8, 2022

Conference call and webcast to be held today at 8:00 a.m. Eastern TimeSOUTH SAN FRANCISCO, Calif., June 8, 2022 /PRNewswire/ -- Rigel Pharmaceutic...

Source: businessinsider.com

Positive Phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine

Published: April 15, 2022

Results published today in the New England Journal of Medicine showed that treatment with rilzabrutinib resulted in a rapid and durable increase in platelet count in patients with heavily pretreated immune thrombocytopenia (ITP)

Source: pressreleasepoint.com

Sanofi - Aventis Groupe: Press Release: Positive Phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine

Published: April 14, 2022

Positive Phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine Results published today in the New England Journal of

Source: finanznachrichten.de

BTK Inhibitor Shows Potential in Immune Thrombocytopenia

Published: April 13, 2022

Across doses, 40% of heavily pretreated patients responded to oral rilzabrutinib

Source: medpagetoday.com